Human Augmentation in Healthcare 2018 – 2023

Table of Contents

1 Introduction
1.1 What is Bionics?
1.2 Bionics Products and Application Industry
1.3 Bionics Growth Driver
1.3.1 Healthcare Technology Advancement
1.3.2 Aging Population to Increase Organ Failure
1.3.3 Accident to Amputations
1.3.4 Exoskeleton Application
1.3.5 Substitute of Robotics
1.3.6 Government R&D Initiative
1.3.7 Increase of Income Especially in Emerging Economies
1.4 Bionics Market Limitations
1.4.1 High Cost of Device and Treatment
1.4.2 Government Regulations and Strict Approval process
1.4.3 Lack of Surgical Expertise
1.5 Bionics Impact on Society
1.5.1 Positive Impact
1.5.2 Negative Impact
2 Bionics Technology and Market Development
2.1 Medical Bionics Products
2.2 Orthotics and Prosthetics
2.3 Artificial Organ
2.4 Powered Exoskeleton
2.4.1 Medical Exoskeleton
2.4.2 Military Exoskeleton
2.4.3 Assistive Exoskeleton
2.5 Human Bionics
2.6 Mechanical vs. Electronics Bionics
2.7 Artificial Implants vs. Wearable Bionics
2.8 3D Printing and Bionics
2.9 Bionics and Artificial Intelligence
2.10 Nanotechnology and Bionics
2.11 Business Biomimetic
2.12 Cybernetic Organism
2.13 Bionics Industry Landscape
3 Bionics Market and Revenue Forecast
3.1 Combined Bionics Revenue 2018 – 2023
3.2 Bionics Revenue by Industry Vertical 2018 – 2023
3.3 Medical Bionics Revenue 2018 – 2023
3.3.1 Medical Bionics Revenue by Product Category
3.3.1.1 Orthopedic Bionics Revenue by Product Type
3.3.1.1.1 Bionics Limbs Revenue by Product Type
3.3.1.1.2 Bionics Lower Limbs Revenue by Product Type
3.3.1.1.3 Electrical Bone Growth Stimulators Revenue by Product Type
3.3.1.2 Cardiac Bionics Revenue by Product Type
3.3.1.2.1 Artificial Organ Revenue by Product Type
3.3.1.2.2 Artificial Heart Valves Revenue by Product Type
3.3.1.2.3 Bionics Pacemaker Revenue by Product Type
3.3.1.2.4 Bionics Ventricular assist device (VADs) Revenue by Product Type
3.3.1.3 Neural/Brain Bionics Revenue by Product Type
3.3.1.3.1 Bionics Internal Neurostimulators Revenue by Product Type
3.3.1.4 Bionics Ear Revenue by Product Type
3.3.2 Medical Bionics Revenue by Application Type
3.3.2.1 Implantable Medical Bionics Revenue by Product Type
3.3.2.2 Externally Worn Medical Bionics Revenue by Product Type
3.3.3 Medical Bionics Revenue by Technology Type
3.3.3.1 Medical Mechanical Bionics Revenue by Product Type
3.3.3.2 Medical Electronic Bionics Revenue by Product Type
3.3.4 Medical Bionics Revenue by End User Type
3.3.5 Medical Bionics Revenue by Region
3.3.5.1 North America Medical Bionics Revenue by Country
3.3.5.2 Europe Medical Bionics Revenue by Country
3.3.5.3 APAC Medical Bionics Revenue by Country
3.3.5.3.1 SEA Medical Bionics Revenue by Country
3.3.5.4 LAMEA Medical Bionics Revenue by Country
3.4 Defense Exoskeleton Bionics Revenue 2018 – 2023
3.4.1 Defense Exoskeleton Bionics Revenue by Product Category
3.4.2 Defense Exoskeleton Bionics Revenue by Technology Type
3.4.3 Defense Exoskeleton Bionics Revenue by Region
3.4.3.1 North America Defense Exoskeleton Bionics Revenue by Country
3.4.3.2 APAC Defense Exoskeleton Bionics Revenue by Country
3.4.3.3 Europe Defense Exoskeleton Bionics Revenue by Country
3.4.3.4 ROW Defense Exoskeleton Bionics Revenue by Country
4 Company and Analysis
4.1 Abbott Laboratories
4.2 AbbVie Inc.
4.3 Abiomed
4.4 Asahi Kasei Kuraray Medical Co. Ltd.
4.5 Baxter International
4.6 Zimmer Biomet Holdings
4.7 Boston Scientific Corporation
4.8 Cochlear Ltd.
4.9 Edwards Lifesciences Corporation
4.10 Ekso Bionics Holdings Inc.
4.11 LivaNova PLC
4.12 Medtronic plc
4.13 Orthofix Holdings Inc.
4.14 Otto Bock HealthCare GmBH
4.15 Retina Implant AG
4.16 Sonova Holding AG
4.17 Ossur Corporate
4.18 SynCardia Systems LLC
4.19 20 Knots Plus Ltd (20KTS+)
4.20 Bionic Power
4.21 ExoAtlet
4.22 Lockheed Martin Corporation
4.23 RB3D
4.24 Sarcos Corporation
4.25 Spring Active
4.26 SRI International
5 Conclusions and Market Outlook
5.1 Real Life Bionic Human
5.2 Human Assistance
5.3 Cloud Bionics